Search Within

Henry Stuart Walch

  1. "Body Imaging Service"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
Groups
  1. Body Imaging Service (8)
  2. Department of Medicine (8)
  3. Epidemiology and Biostatistics (8)
  4. Gastrointestinal Oncology Service (8)
  5. Radiology, Department of (8)
  6. Solid Tumor Oncology Division (8)

More Groups

People
  1. Kinh Gian Do (6)
  2. Nikolaus Schultz (6)
  3. David Solit (5)
  4. Jinru Shia (5)
  5. Walid Chatila (5)
  6. Darren Cowzer (4)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (1)
  5. 2021 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Annals of Oncology (1)
  3. Annals of Surgical Oncology (1)
  4. Clinical Cancer Research (1)
  5. JNCI: Journal of the National Cancer Institute (1)
  6. The Oncologist (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Oxford University Press (3)
  3. American Association for Cancer Research (1)
  4. Springer (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy
    Journal Article

    Cowzer, D.; Soares, K.; Walch, H.; Gönen, M.; Boucher, T. M.; Do, R. K. G.; Harding, J. J.; Varghese, A. M.; Reidy-Lagunes, D.; Saltz, L.; more...
    JNCI: Journal of the National Cancer Institute (2025)

    Fulltext@MSK | Save
  • Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository
    Meeting Abstract

    Cowzer, D.; Walch, H. S.; Atri, P.; Shah, F.; Huq, R.; Khalil, D. N.; Park, W.; Yeh, R.; Do, R. K. G.; Basturk, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy
    Journal Article

    Cowzer, D.; Chou, J. F.; Walch, H.; Keane, F.; Khalil, D.; Shia, J.; Do, R. K. G.; Yarmohammadi, H.; Erinjeri, J. P.; El Dika, I.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Durable complete responses to PD-1 blockade alone in mismatch repair deficient locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Sinopoli, J. C.; Shia, J.; Weiss, J. A.; Temple, L.; Smith, J. J.; Saltz, L. B.; Widmar, M.; Fumo, G.; Aparo, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Meeting Abstract

    Cowzer, D.; Capanu, M.; Keane, F.; Khalil, D.; Shia, J.; Do, R.; Chou, J.; Walch, H.; El Dika, I.; Yaqubie, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Local therapy for oligoprogression or consolidation in high mutational burden stage 4 colorectal cancer treated with PD-1 or PD-L1 blockade
    Journal Article

    Klemen, N. D.; Court, C. M.; Fernandes, M. C.; Walch, H. S.; Chatila, W. K.; Saadat, L. V.; Maron, S.; Crane, C.; Shia, J.; Cercek, A.; more...
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save